Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-31
DOI
10.1007/s00262-018-2267-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SEA-CD40, a non-fucosylated CD40 agonist: Interim results from a phase 1 study in advanced solid tumors.
- (2018) Juneko E. Grilley-Olson et al. JOURNAL OF CLINICAL ONCOLOGY
- Agonistic CD40 mAb-Driven IL12 Reverses Resistance to Anti-PD1 in a T-cell–Rich Tumor
- (2016) Shin Foong Ngiow et al. CANCER RESEARCH
- Cancer immunotherapy: activating innate and adaptive immunity through CD40 agonists
- (2016) Gregory L. Beatty et al. Expert Review of Anticancer Therapy
- A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma
- (2015) A. K. Nowak et al. ANNALS OF ONCOLOGY
- Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers
- (2015) N Anandasabapathy et al. BONE MARROW TRANSPLANTATION
- Conformation of the Human Immunoglobulin G2 Hinge Imparts Superagonistic Properties to Immunostimulatory Anticancer Antibodies
- (2015) Ann L. White et al. CANCER CELL
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- The Human Agonistic CD40 Antibody ADC-1013 Eradicates Bladder Tumors and Generates T-cell-Dependent Tumor Immunity
- (2014) S. M. Mangsbo et al. CLINICAL CANCER RESEARCH
- Immune Activation and a 9-Year Ongoing Complete Remission Following CD40 Antibody Therapy and Metastasectomy in a Patient with Metastatic Melanoma
- (2014) D. L. Bajor et al. Cancer Immunology Research
- A Short History of the B-Cell-Associated Surface Molecule CD40
- (2014) Edward A. Clark Frontiers in Immunology
- A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma
- (2013) G. L. Beatty et al. CLINICAL CANCER RESEARCH
- Agonistic CD40 Antibodies and Cancer Therapy
- (2013) R. H. Vonderheide et al. CLINICAL CANCER RESEARCH
- Cysteine-rich Domain 1 of CD40 Mediates Receptor Self-assembly
- (2013) Cristian R. Smulski et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Expression of CD40 and growth-inhibitory activity of CD40 agonist in ovarian carcinoma cells
- (2012) Yan Zhou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immune modulation with weekly dosing of an agonist CD40 antibody in a phase I study of patients with advanced solid tumors
- (2011) Jens Rüter et al. CANCER BIOLOGY & THERAPY
- The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice
- (2011) Ronald P. Gladue et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Crystallographic and Mutational Analysis of the CD40-CD154 Complex and Its Implications for Receptor Activation
- (2011) Hyun-Jung An et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interaction with Fc RIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody
- (2011) A. L. White et al. JOURNAL OF IMMUNOLOGY
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- Inhibitory Fc Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies
- (2011) F. Li et al. SCIENCE
- Phase I Study of the Humanized Anti-CD40 Monoclonal Antibody Dacetuzumab in Refractory or Recurrent Non-Hodgkin's Lymphoma
- (2009) Ranjana Advani et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved in vitro methods to predict the in vivo toxicity in man of therapeutic monoclonal antibodies including TGN1412
- (2009) Lucy Findlay et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Expression of CD40 and growth-inhibitory activity of CD40 ligand in colon cancer ex vivo
- (2008) Yugang Wu et al. CELLULAR IMMUNOLOGY
- CD40L-mediated inhibition of NF-kappaB in CA46 Burkitt lymphoma cells promotes apoptosis
- (2008) Shaoyuan Wang et al. LEUKEMIA & LYMPHOMA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now